{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:00:41Z","timestamp":1756897241183},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,29]]},"DOI":"10.7759\/cureus.53147","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T11:26:29Z","timestamp":1706527589000},"source":"Crossref","is-referenced-by-count":3,"title":["Comparing Complications and Patient Satisfaction Following Injectable Collagenase Versus Limited Fasciectomy for Dupuytren\u2019s Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Zainah A","family":"Alhebshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya O","family":"Bamuqabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Alqurain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Dahlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan I","family":"Wasaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad S","family":"Al Saedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gutaybah  S","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danah","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayan","family":"Ghalimah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1874325001105010283","article-title":"Dupuytren\u2019s disease: review of the current literature","volume":"5 Suppl 2","author":"Khashan M","year":"2011","unstructured":"Khashan M, Smitham PJ, Khan WS, Goddard NJ. Dupuytren\u2019s disease: review of the current literature. Open Orthop J. 2011, 5 Suppl 2:283-8. 10.2174\/1874325001105010283","journal-title":"Open Orthop J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hcl.2018.03.002","article-title":"Risk factors, disease associations, and Dupuytren diathesis","volume":"34","author":"Hindocha S","year":"2018","unstructured":"Hindocha S. Risk factors, disease associations, and Dupuytren diathesis. Hand Clin. 2018, 34:307-14. 10.1016\/j.hcl.2018.03.002","journal-title":"Hand Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-117","article-title":"Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes","volume":"15","author":"Eckerdal D","year":"2014","unstructured":"Eckerdal D, Nivestam A, Dahlin LB. Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes. BMC Musculoskelet Disord. 2014, 15:117. 10.1186\/1471-2474-15-117","journal-title":"BMC Musculoskelet Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2009.08.005","article-title":"Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture","volume":"34","author":"Verjee LS","year":"2009","unstructured":"Verjee LS, Midwood K, Davidson D, Essex D, Sandison A, Nanchahal J. Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture. J Hand Surg Am. 2009, 34:1785-94. 10.1016\/j.jhsa.2009.08.005","journal-title":"J Hand Surg Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386456-7.04403-8","article-title":"Superficial dermal and fascial fibromatoses","author":"Yvon A","year":"2014","unstructured":"Yvon A, Volk SW, Bayat A. Superficial dermal and fascial fibromatoses. Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. McManus LM, Mitchell RN (ed): Academic Press, Cambridge, MA; 2014. 1967-81. 10.1016\/B978-0-12-386456-7.04403-8"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.62985","article-title":"Dupuytren's disease","volume":"76","author":"Saraf S","year":"2010","unstructured":"Saraf S. Dupuytren's disease. Indian J Dermatol Venereol Leprol. 2010, 76:291-3. 10.4103\/0378-6323.62985","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2019.07.027","article-title":"Dupuytren contracture as a sign of systemic disease","volume":"37","author":"Bogdanov I","year":"2019","unstructured":"Bogdanov I, Rowland Payne C. Dupuytren contracture as a sign of systemic disease. Clin Dermatol. 2019, 37:675-8. 10.1016\/j.clindermatol.2019.07.027","journal-title":"Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-01999-7","article-title":"The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis","volume":"15","author":"Salari N","year":"2020","unstructured":"Salari N, Heydari M, Hassanabadi M, et al.. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2020, 15:495. 10.1186\/s13018-020-01999-7","journal-title":"J Orthop Surg Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/229255030000800502","article-title":"Dupuytren\u2019s disease in Saudi Arabia","volume":"8","author":"Al-Qattan M","year":"2000","unstructured":"Al-Qattan M. Dupuytren\u2019s disease in Saudi Arabia. Can J Plast Surg. 2000, 8:185-6. 10.1177\/229255030000800502","journal-title":"Can J Plast Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hcl.2018.03.010","article-title":"Advances in minimally invasive treatment of Dupuytren disease","volume":"34","author":"Hovius SE","year":"2018","unstructured":"Hovius SE, Zhou C. Advances in minimally invasive treatment of Dupuytren disease. Hand Clin. 2018, 34:417-26. 10.1016\/j.hcl.2018.03.010","journal-title":"Hand Clin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1200-y","article-title":"Systematic review of non-surgical treatments for early dupuytren's disease","volume":"17","author":"Ball C","year":"2016","unstructured":"Ball C, Izadi D, Verjee LS, Chan J, Nanchahal J. Systematic review of non-surgical treatments for early dupuytren's disease. BMC Musculoskelet Disord. 2016, 17:345. 10.1186\/s12891-016-1200-y","journal-title":"BMC Musculoskelet Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004046","article-title":"Treatment options for Dupuytren\u2019s disease: tips and tricks","volume":"10","author":"Denkler KA","year":"2022","unstructured":"Denkler KA, Park KM, Alser O. Treatment options for Dupuytren\u2019s disease: tips and tricks. Plast Reconstr Surg Glob Open. 2022, 10:e4046. 10.1097\/GOX.0000000000004046","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hcl.2018.04.002","article-title":"Fasciectomy for Dupuytren contracture","volume":"34","author":"Dias JJ","year":"2018","unstructured":"Dias JJ, Aziz S. Fasciectomy for Dupuytren contracture. Hand Clin. 2018, 34:351-66. 10.1016\/j.hcl.2018.04.002","journal-title":"Hand Clin"},{"key":"ref14","article-title":"Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature","volume":"10","author":"Denkler K","year":"2010","unstructured":"Denkler K. Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature. Eplasty. 2010, 10:e15.","journal-title":"Eplasty"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2014.013","article-title":"Collagenase Clostridium histolyticum for Dupuytren\u2019s contracture","volume":"37","year":"2014","unstructured":"Collagenase Clostridium histolyticum for Dupuytren\u2019s contracture. Australian Prescriber. 2014, 37.28-35. 10.18773\/austprescr.2014.013","journal-title":"Australian Prescriber"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-55140-3.00013-8","article-title":"Biologics in hand surgery","author":"Yoshida R","year":"2019","unstructured":"Yoshida R, Baron S, Rodner C, Ferreira J. Biologics in hand surgery. Biologics in Orthopaedic Surgery. 2019, 135-9. 10.1016\/B978-0-323-55140-3.00013-8","journal-title":"Biologics in Orthopaedic Surgery"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-011-9326-8","article-title":"A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture","volume":"6","author":"Chen NC","year":"2011","unstructured":"Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (N Y). 2011, 6:250-5. 10.1007\/s11552-011-9326-8","journal-title":"Hand (N Y)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim K","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003, 73:712-6. 10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-7-44","article-title":"The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH","volume":"7","author":"Gummesson C","year":"2006","unstructured":"Gummesson C, Ward MM, Atroshi I. The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord. 2006, 7:44. 10.1186\/1471-2474-7-44","journal-title":"BMC Musculoskelet Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000003581","article-title":"Normative values of the Michigan hand outcomes questionnaire for patients with and without hand conditions","volume":"140","author":"Nolte MT","year":"2017","unstructured":"Nolte MT, Shauver MJ, Chung KC. Normative values of the Michigan hand outcomes questionnaire for patients with and without hand conditions. Plast Reconstr Surg. 2017, 140:425e-33e. 10.1097\/PRS.0000000000003581","journal-title":"Plast Reconstr Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20564","article-title":"Unit\u00e9 rhumatologique des affections de la main (Uram) scale: development and validation of a tool to assess Dupuytren\u2019s disease-specific disability","volume":"63","author":"Beaudreuil J","year":"2011","unstructured":"Beaudreuil J, Allard A, Zerkak D, et al.. Unit\u00e9 rhumatologique des affections de la main (Uram) scale: development and validation of a tool to assess Dupuytren\u2019s disease-specific disability. Arthritis Care Res (Hoboken). 2011, 63:1448-55. 10.1002\/acr.20564","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0537-z","article-title":"Assessing the performance of the EQ-VAS in the NHS PROMs programme","volume":"23","author":"Feng Y","year":"2014","unstructured":"Feng Y, Parkin D, Devlin NJ. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res. 2014, 23:977-89. 10.1007\/s11136-013-0537-z","journal-title":"Qual Life Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2490\/prm.20210023","article-title":"Collagenase Clostridium histolyticum injection therapy improves health-related quality of life in patients with Dupuytren\u2019s disease","volume":"6","author":"Kuboi T","year":"2021","unstructured":"Kuboi T, Tajika T, Endo F, et al.. Collagenase Clostridium histolyticum injection therapy improves health-related quality of life in patients with Dupuytren\u2019s disease. Prog Rehabil Med. 2021, 6:20210023. 10.2490\/prm.20210023","journal-title":"Prog Rehabil Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12966-z","article-title":"The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness","volume":"12","author":"Yamamoto M","year":"2022","unstructured":"Yamamoto M, Yasunaga H, Kakinoki R, et al.. The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness. Sci Rep. 2022, 12:9094. 10.1038\/s41598-022-12966-z","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-018-3034-6","article-title":"Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients","volume":"138","author":"Lecl\u00e8re FM","year":"2018","unstructured":"Lecl\u00e8re FM, Kohl S, Varonier C, Unglaub F, V\u00f6gelin E. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients. Arch Orthop Trauma Surg. 2018, 138:1623-31. 10.1007\/s00402-018-3034-6","journal-title":"Arch Orthop Trauma Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1142\/S0218810415500288","article-title":"Comparison between collagenase injection and partial fasciectomy in the treatment of Dupuytren\u2019s contracture","volume":"20","author":"Tay TK","year":"2015","unstructured":"Tay TK, Tien H, Lim EY. Comparison between collagenase injection and partial fasciectomy in the treatment of Dupuytren\u2019s contracture. Hand Surg. 2015, 20:386-90. 10.1142\/S0218810415500288","journal-title":"Hand Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000001320","article-title":"Collagenase Clostridium histolyticum versus limited fasciectomy for Dupuytren\u2019s contracture: outcomes from a multicenter propensity score matched study","volume":"136","author":"Zhou C","year":"2015","unstructured":"Zhou C, Hovius SE, Slijper HP, Feitz R, Van Nieuwenhoven CA, Pieters AJ, Selles RW. Collagenase Clostridium histolyticum versus limited fasciectomy for Dupuytren\u2019s contracture: outcomes from a multicenter propensity score matched study. Plast Reconstr Surg. 2015, 136:87-97. 10.1097\/PRS.0000000000001320","journal-title":"Plast Reconstr Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1142\/S021881041450021X","article-title":"Resource utilisation associated with single digit Dupuytren's contracture treated with either surgery or injection of collagenase Clostridium histolyticum","volume":"19","author":"Povlsen B","year":"2014","unstructured":"Povlsen B, Shields AM, Bhabra GS. Resource utilisation associated with single digit Dupuytren's contracture treated with either surgery or injection of collagenase Clostridium histolyticum. Hand Surg. 2014, 19:205-9. 10.1142\/S021881041450021X","journal-title":"Hand Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-013-9540-7","article-title":"Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture","volume":"8","author":"Naam NH","year":"2013","unstructured":"Naam NH. Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture. Hand (N Y). 2013, 8:410-6. 10.1007\/s11552-013-9540-7","journal-title":"Hand (N Y)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000002472","article-title":"Predictors of patient satisfaction with hand function after fasciectomy for Dupuytren\u2019s contracture","volume":"138","author":"Zhou C","year":"2016","unstructured":"Zhou C, Hovius SE, Slijper HP, Zuidam MJ, Smit X, Feitz R, Selles RW. Predictors of patient satisfaction with hand function after fasciectomy for Dupuytren\u2019s contracture. Plast Reconstr Surg. 2016, 138:649-55. 10.1097\/PRS.0000000000002472","journal-title":"Plast Reconstr Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2006.02.021","article-title":"A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study","volume":"31","author":"van Rijssen AL","year":"2006","unstructured":"van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006, 31:717-25. 10.1016\/j.jhsa.2006.02.021","journal-title":"J Hand Surg Am"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s12306-013-0304-x","article-title":"Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases","volume":"98","author":"Alberton F","year":"2014","unstructured":"Alberton F, Corain M, Garofano A, Pangallo L, Valore A, Zanella V, Adani R. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases. Musculoskelet Surg. 2014, 98:225-32. 10.1007\/s12306-013-0304-x","journal-title":"Musculoskelet Surg"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000006828","article-title":"Comparison of treatment outcomes after collagenase injection and percutaneous needle fasciotomy for Dupuytren\u2019s contracture: objective and subjective comparisons with a 3-year follow-up","volume":"145","author":"Abe Y","year":"2020","unstructured":"Abe Y. Comparison of treatment outcomes after collagenase injection and percutaneous needle fasciotomy for Dupuytren\u2019s contracture: objective and subjective comparisons with a 3-year follow-up. Plast Reconstr Surg. 2020, 145:1464-74. 10.1097\/PRS.0000000000006828","journal-title":"Plast Reconstr Surg"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2018.05.012","article-title":"Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: a prospective study","volume":"104","author":"Sanjuan-Cerver\u00f3 R","year":"2018","unstructured":"Sanjuan-Cerver\u00f3 R, Carrera-Hueso FJ, Vazquez-Ferreiro P. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: a prospective study. Orthop Traumatol Surg Res. 2018, 104:901-5. 10.1016\/j.otsr.2018.05.012","journal-title":"Orthop Traumatol Surg Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2020.03.028","article-title":"Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: a prospective study","volume":"21","author":"De Vitis R","year":"2020","unstructured":"De Vitis R, Passiatore M, Perna A, Careri S, Cilli V, Taccardo G. Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: a prospective study. J Orthop. 2020, 21:218-22. 10.1016\/j.jor.2020.03.028","journal-title":"J Orthop"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1590\/1413-785220233101e259218","article-title":"Clinical results of collagenase treatment for Dupuytren\u2019s disease: a case series study with 2-years follow-up","volume":"31","author":"Basso MA","year":"2023","unstructured":"Basso MA, Bernasconi A, Balato G, Cozzolino A, Famiglietti G, Smeraglia F. Clinical results of collagenase treatment for Dupuytren\u2019s disease: a case series study with 2-years follow-up. Acta Ortop Bras. 2023, 31:e259218. 10.1590\/1413-785220233101e259218","journal-title":"Acta Ortop Bras"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1590\/1413-785220172503164827","article-title":"Surgical treatment results for dupuytren's disease","volume":"25","author":"Aykut S","year":"2017","unstructured":"Aykut S, Baydar M, B\u00fcy\u00fck AF, \u00d6zt\u00fcrk \u0130A, \u00d6zden E, \u00d6zt\u00fcrk K. Surgical treatment results for dupuytren's disease. Acta Ortop Bras. 2017, 25:71-3. 10.1590\/1413-785220172503164827","journal-title":"Acta Ortop Bras"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1725221","article-title":"Comparison of hand therapy with or without splinting post fasciectomy for Dupuytren\u2019s contracture: systematic review and meta-analysis","volume":"14","author":"Karam M","year":"2022","unstructured":"Karam M, Kahlar N, Abul A, Rahman S, Pinder R. Comparison of hand therapy with or without splinting post fasciectomy for Dupuytren\u2019s contracture: systematic review and meta-analysis. J Hand Microsurg. 2022, 14:308-14. 10.1055\/s-0041-1725221","journal-title":"J Hand Microsurg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/2309499020921747","article-title":"The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: a meta-analysis","volume":"28","author":"Cooper TB","year":"2020","unstructured":"Cooper TB, Poonit K, Yao C, Jin Z, Zheng J, Yan H. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: a meta-analysis. J Orthop Surg (Hong Kong). 2020, 28:2309499020921747. 10.1177\/2309499020921747","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000278455.63546.03","article-title":"Dupuytren's disease: history, diagnosis, and treatment","volume":"120","author":"Shaw RB Jr","year":"2007","unstructured":"Shaw RB Jr, Chong AK, Zhang A, Hentz VR, Chang J. Dupuytren's disease: history, diagnosis, and treatment. Plast Reconstr Surg. 2007, 120:44e-54e. 10.1097\/01.prs.0000278455.63546.03","journal-title":"Plast Reconstr Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.103B5.BJJ-2020-1393.R2","article-title":"Repeat limited fasciectomy is a safe and effective treatment for recurrence of Dupuytren's disease","volume":"103-B","author":"Ashdown T","year":"2021","unstructured":"Ashdown T, Hayter E, Morris JA, Clough OT, Little M, Hardman J, Anakwe RE. Repeat limited fasciectomy is a safe and effective treatment for recurrence of Dupuytren's disease. Bone Joint J. 2021, 103-B:946-50. 10.1302\/0301-620X.103B5.BJJ-2020-1393.R2","journal-title":"Bone Joint J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000001247","article-title":"Multiple recurrences in aggressive forms of Dupuytren\u2019s disease-can patients benefit from repeated selective fasciectomy?","volume":"5","author":"K\u00f6nneker S","year":"2017","unstructured":"K\u00f6nneker S, Broelsch GF, Krezdorn N, Dastagir K, Kuhbier JW, Paprottka FJ, Vogt PM. Multiple recurrences in aggressive forms of Dupuytren\u2019s disease-can patients benefit from repeated selective fasciectomy?. Plast Reconstr Surg Glob Open. 2017, 5:e1247. 10.1097\/GOX.0000000000001247","journal-title":"Plast Reconstr Surg Glob Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224725-comparing-complications-and-patient-satisfaction-following-injectable-collagenase-versus-limited-fasciectomy-for-dupuytrens-disease-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:57Z","timestamp":1707509697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224725-comparing-complications-and-patient-satisfaction-following-injectable-collagenase-versus-limited-fasciectomy-for-dupuytrens-disease-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.53147","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}